BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Karyopharm Therapeutics 



Newton  Massachusetts    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Biotechnology






 Company News
Karyopharm Therapeutics (KPTI) Announces Full Exercise Of Underwriters Option To Purchase Additional Shares In Public Offering Of Common Stock 6/30/2014 7:44:47 AM
Karyopharm Therapeutics (KPTI) Announces Pricing Of Public Offering of Common Stock 6/27/2014 7:24:26 AM
Karyopharm Therapeutics (KPTI) Announces Proposed Public Offering Of Common Stock 6/26/2014 7:40:39 AM
Karyopharm Therapeutics (KPTI) Initiates Registration-Directed, Randomized Study Of Selinexor (KPT-330) In Older Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) 6/24/2014 9:00:59 AM
Veristat, Inc. And Karyopharm Therapeutics (KPTI) Enter Into Preferred Provider Agreement For Oncology And Novel Therapeutic Advancement 6/16/2014 10:27:53 AM
Karyopharm Therapeutics (KPTI) Announces: FDA Considers The Effectiveness And Safety Technical Sections Complete To Support Conditional Approval For The New Animal Drug Application For Verdinexor (KPT-335) To Treat Lymphoma In Client Owned Dogs 6/16/2014 7:35:25 AM
Karyopharm Therapeutics (KPTI) Announces First Combination Data Of Selinexor With Low-Dose Dexamethasone In Heavily Pretreated Multiple Myeloma Patients 6/13/2014 8:14:08 AM
Karyopharm Therapeutics (KPTI) Announces Initiation Of Phase 2 Study Of Selinexor (KPT-330) In Patients With Hormone Refractory Prostate Cancer (SHIP Study) 6/9/2014 9:22:33 AM
Karyopharm Therapeutics (KPTI) Provides Data Update For Selinexor In Non-Hodgkin's Lymphoma And Acute Myeloid Leukemia At 2014 American Society of Clinical Oncology Annual Meeting 6/2/2014 9:40:58 AM
Karyopharm Therapeutics (KPTI) Updates Data For Selinexor In Solid Tumors At 2014 American Society of Clinical Oncology Annual Meeting 6/2/2014 9:16:07 AM
1234567